Renal biochemistry in rheumatic disease

Adams, 1986, Non-steroidal anti-inflammatory drugs and renal failure, Lancet, i, 57, 10.1016/S0140-6736(86)90714-2 1982 Baxter, 1982, Hyperlipoproteinaemia in nephrosis, Archives of Internal Medicine, 109, 742, 10.1001/archinte.1962.03620180104012 Berg, 1977, Acute effects of acetylsalicylic acid in patients with chronic renal insufficiency, European Journal of Clinical Pharmacology, 11, 111, 10.1007/BF00562901 Bird, 1984, Renal proximal tubular dysfunction in patients with rheumatic diseases, British Medical Journal, 288, 1044, 10.1136/bmj.288.6423.1044-a Clive, 1984, Renal syndromes associated with non-steroidal anti-inflammatory drugs, New England Journal of Medicine, 310, 563, 10.1056/NEJM198403013100905 Cockroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580 Dilena, 1983, Six methods for determining urinary protein compared, Clinical Chemistry, 29, 553, 10.1093/clinchem/29.3.553 Donadio, 1982, Renal involvement in SLE: the argument for aggressive treatment, 45 Helin, 1986, Mild mesangial glomerulopathy—a frequent finding in rheumatoid arthritis patients with haematuria or proteinuria, Nephron, 42, 224, 10.1159/000183671 Hordon, 1984, Haematuria in rheumatoid arthritis: an association with mesangial glomerulonephritis, Annals of the Rheumatic Diseases, 43, 440, 10.1136/ard.43.3.440 Kimberly, 1977, Aspirin-induced depression of renal function, New England Journal of Medicine, 296, 418, 10.1056/NEJM197702242960803 Kleinknecht, 1986, Analgesic and non-steroidal anti-inflammatory drug-associated acute renal failure: a prospective collaborative study, Clinical Nephrology, 25, 273 Laakso, 1986, Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis, Annals of the Rheumatic Diseases, 45, 663, 10.1136/ard.45.8.663 McEldery, 1982, Six methods for urinary protein compared, Clinical Chemistry, 28, 356, 10.1093/clinchem/28.2.356 Macias Nunez, 1987 Maury, 1985, Rheumatoid factor and amyloidosis in rheumatoid arthritis, British Medical Journal, 291, 1015, 10.1136/bmj.291.6501.1015 Maury, 1985, Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis, International Journal on Tissue Reactions, 7, 405 Merle, 1980, Renal injury in patients with rheumatoid arthritis treated with gold, Clinical Pharmacology and Therapeutics, 28, 216, 10.1038/clpt.1980.153 Mitch, 1976, A simple method of estimating progression of chronic renal failure, Lancet, ii, 1326, 10.1016/S0140-6736(76)91974-7 Payne, 1986, Creatinine clearance: a redundant clinical investigation, Annals of Clinical Biochemistry, 23, 243, 10.1177/000456328602300304 Rehling, 1984, Simultaneous measurement of renal clearance and plasma clearance of 99Tc-labelled diethylenetriamine penta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and insulin in man, Clinical Science, 66, 613, 10.1042/cs0660613 Schumann, 1986, Cytodiagnostic urinalysis for the nephrology practice, Seminars in Nephrology, 6, 308 Schwartz, 1987, The use of plasma creatinine concentration for estimating glomerular filtration role in infants, children and adolescents, Pediatric Clinics of North America, 34, 571, 10.1016/S0031-3955(16)36251-4 Spencer, 1986, Analytical reviews in clinical biochemistry: the estimation of creatinine, Annals of Clinical Biochemistry, 23, 1, 10.1177/000456328602300101 Vanderlinde, 1981, Urinary enzyme measurements in the diagnosis of renal disorders, Annals of Clinical and Laboratory Science, 11, 189 Wegelius, 1980, Follow up study of amyloidosis secondary to rheumatic disease, 183 Whiting, 1983, N-Acetyl-beta-d-glucosaminidase levels and the onset of diabetic microangiopathy, Annals of Clinical Biochemistry, 120, 15, 10.1177/000456328302000102 Wills, 1985, Uremic toxins and their effect on intermediary metabolism, Clinical Chemistry, 31, 5, 10.1093/clinchem/31.1.5